Tarsus Pharmaceuticalsinc Stock Price To Earnings To Growth
| TARS Stock | USD 38.58 0.08 0.21% |
Tarsus PharmaceuticalsInc fundamentals help investors to digest information that contributes to Tarsus PharmaceuticalsI's financial success or failures. It also enables traders to predict the movement of Tarsus Stock. The fundamental analysis module provides a way to measure Tarsus PharmaceuticalsI's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tarsus PharmaceuticalsI stock.
Tarsus | Price To Earnings To Growth |
Tarsus PharmaceuticalsInc Company Price To Earnings To Growth Analysis
Tarsus PharmaceuticalsI's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Tarsus PharmaceuticalsI Price To Earnings To Growth | 0.28 X |
Most of Tarsus PharmaceuticalsI's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tarsus PharmaceuticalsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Tarsus Price To Earnings To Growth Driver Correlations
Understanding the fundamental principles of building solid financial models for Tarsus PharmaceuticalsI is extremely important. It helps to project a fair market value of Tarsus Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Tarsus PharmaceuticalsI's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Tarsus PharmaceuticalsI's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Tarsus PharmaceuticalsI's interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Tarsus Price Earnings To Growth Ratio
Price Earnings To Growth Ratio |
|
Based on the latest financial disclosure, Tarsus PharmaceuticalsInc has a Price To Earnings To Growth of 0.28 times. This is 60.56% lower than that of the Pharmaceuticals sector and 91.08% lower than that of the Health Care industry. The price to earnings to growth for all United States stocks is 94.27% higher than that of the company.
Tarsus Price To Earnings To Growth Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tarsus PharmaceuticalsI's direct or indirect competition against its Price To Earnings To Growth to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tarsus PharmaceuticalsI could also be used in its relative valuation, which is a method of valuing Tarsus PharmaceuticalsI by comparing valuation metrics of similar companies.Tarsus PharmaceuticalsI is currently under evaluation in price to earnings to growth category among related companies.
Tarsus PharmaceuticalsI ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Tarsus PharmaceuticalsI's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Tarsus PharmaceuticalsI's managers, analysts, and investors.Environmental | Governance | Social |
Tarsus Fundamentals
| Return On Equity | -0.66 | ||||
| Return On Asset | -0.35 | ||||
| Operating Margin | (1.36) % | ||||
| Current Valuation | 1.17 B | ||||
| Shares Outstanding | 37.78 M | ||||
| Shares Owned By Insiders | 8.66 % | ||||
| Shares Owned By Institutions | 91.34 % | ||||
| Number Of Shares Shorted | 7.66 M | ||||
| Price To Book | 6.90 X | ||||
| Price To Sales | 77.74 X | ||||
| Revenue | 17.45 M | ||||
| Gross Profit | (17.76 M) | ||||
| EBITDA | (142.28 M) | ||||
| Net Income | (135.89 M) | ||||
| Cash And Equivalents | 245.36 M | ||||
| Cash Per Share | 9.20 X | ||||
| Total Debt | 31.73 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 21.36 X | ||||
| Book Value Per Share | 7.29 X | ||||
| Cash Flow From Operations | (117.49 M) | ||||
| Short Ratio | 14.77 X | ||||
| Earnings Per Share | (4.75) X | ||||
| Price To Earnings To Growth | 0.28 X | ||||
| Target Price | 57.38 | ||||
| Number Of Employees | 244 | ||||
| Beta | 1.11 | ||||
| Market Capitalization | 1.45 B | ||||
| Total Asset | 266.22 M | ||||
| Retained Earnings | (244.66 M) | ||||
| Working Capital | 219.19 M | ||||
| Net Asset | 266.22 M |
About Tarsus PharmaceuticalsI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tarsus PharmaceuticalsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tarsus PharmaceuticalsI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tarsus PharmaceuticalsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tarsus PharmaceuticalsI in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tarsus PharmaceuticalsI's short interest history, or implied volatility extrapolated from Tarsus PharmaceuticalsI options trading.
Currently Active Assets on Macroaxis
When determining whether Tarsus PharmaceuticalsInc is a strong investment it is important to analyze Tarsus PharmaceuticalsI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tarsus PharmaceuticalsI's future performance. For an informed investment choice regarding Tarsus Stock, refer to the following important reports:Check out Tarsus PharmaceuticalsI Piotroski F Score and Tarsus PharmaceuticalsI Altman Z Score analysis. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Tarsus Stock analysis
When running Tarsus PharmaceuticalsI's price analysis, check to measure Tarsus PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus PharmaceuticalsI is operating at the current time. Most of Tarsus PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Tarsus PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Tarsus PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Tarsus PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tarsus PharmaceuticalsI. If investors know Tarsus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tarsus PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.75) | Revenue Per Share 1.35 | Quarterly Revenue Growth 10.046 | Return On Assets (0.35) | Return On Equity (0.66) |
The market value of Tarsus PharmaceuticalsInc is measured differently than its book value, which is the value of Tarsus that is recorded on the company's balance sheet. Investors also form their own opinion of Tarsus PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Tarsus PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tarsus PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Tarsus PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tarsus PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tarsus PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tarsus PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.